197 related articles for article (PubMed ID: 28866309)
21. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
22. Mastocytosis.
Abid A; Malone MA; Curci K
Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
[TBL] [Abstract][Full Text] [Related]
23. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
24. Systemic mastocytosis.
Robyn J; Metcalfe DD
Adv Immunol; 2006; 89():169-243. PubMed ID: 16682275
[TBL] [Abstract][Full Text] [Related]
25. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J
Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704
[TBL] [Abstract][Full Text] [Related]
26. Mastocytosis, MCAS, and Related Disorders-Diagnosis, Classification, and Therapy.
Niedoszytko M; Valent P; Nedoszytko B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068468
[TBL] [Abstract][Full Text] [Related]
27. A fractal analysis of the spatial distribution of tumoral mast cells in lymph nodes and bone marrow.
Guidolin D; Marinaccio C; Tortorella C; Ruggieri S; Rizzi A; Maiorano E; Specchia G; Ribatti D
Exp Cell Res; 2015 Nov; 339(1):96-102. PubMed ID: 26358232
[TBL] [Abstract][Full Text] [Related]
28. Stinging Hymenoptera and mastocytosis.
Ruëff F; Dugas-Breit S; Przybilla B
Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic criteria and classification of mastocytosis in 2014.
Akin C; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
[TBL] [Abstract][Full Text] [Related]
30. [Systemic mastocytosis].
Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E
Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160
[TBL] [Abstract][Full Text] [Related]
31. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
Sonneck K; Florian S; Müllauer L; Wimazal F; Födinger M; Sperr WR; Valent P
Int Arch Allergy Immunol; 2007; 142(2):158-64. PubMed ID: 17057414
[TBL] [Abstract][Full Text] [Related]
33. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
34. Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases.
Bridgman DE; Clarke R; Sadleir PH; Stedmon JJ; Platt P
Anaesth Intensive Care; 2013 Jan; 41(1):116-21. PubMed ID: 23362901
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, prognosis, and risk factors in mastocytosis.
Brockow K
Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674
[TBL] [Abstract][Full Text] [Related]
36. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
37. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?
Matito A; Carter M
Curr Allergy Asthma Rep; 2015 May; 15(5):22. PubMed ID: 26139333
[TBL] [Abstract][Full Text] [Related]
39. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
40. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
